De-escalation: In drug we trust

Critical Care Medicine

Volumn 40, Issue 5, 2012, Pages 1645-1646

  Montravers, Philippe ^a   Piednoir, Pascale ^a   Allou, Nicolas ^a  

^a CENTRE HOSPITALIER   (France)

Author keywords

Antibiotic therapy; cost containment; de escalation; multidrug resistant bacteria; nosocomial infection

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CRITICALLY ILL PATIENT; DRUG USE; EDITORIAL; HOSPITAL INFECTION; HUMAN; MEDICAL DECISION MAKING; PRESCRIPTION; PRIORITY JOURNAL; SEPSIS; TREATMENT DURATION; TREATMENT PLANNING;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; FEMALE; HUMANS; MALE; SEPSIS;

EID: 84860246455     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31824317bb     Document Type: Editorial

References (14)

1. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
2. Rello J, Vidaur L, Sandiumenge A, et al: De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 2004; 32:2183-2190
3. Alvarez-Lerma F, Alvarez B, Luque P, et al: Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: A prospective observational study. Crit Care 2006; 10:R78
4. Giantsou E, Liratzopoulos N, Efraimidou E, et al: De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate. Intensive Care Med 2007; 33:1533-1540
5. Canadian Critical Care Trials Group: A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006; 355:2619-2630
6. Leone M, Garcin F, Bouvenot J, et al: Ventilator-associated pneumonia: Breaking the vicious circle of antibiotic overuse. Crit Care Med 2007; 35:379-385; quiz 386
7. Eachempati SR, Hydo LJ, Shou J, et al: Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? J Trauma 2009; 66:1343-1348
8. Leone M, Bourgoin A, Cambon S, et al: Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome. Crit Care Med 2003; 31:462-467
9. Warren MM, Gibb AP, Walsh TS: Antibiotic prescription practice in an intensive care unit using twice-weekly collection of screening specimens: A prospective audit in a large UK teaching hospital. J Hosp Infect 2005; 59:90-95
10. Morel J, Casoetto J, Jospe R, et al: De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit. Crit Care 2010; 14:R225
11. De Waele JJ, Ravyts M, Depuydt P, et al: De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality? J Crit Care 2010; 25:641-646
12. Montravers P, Dupont P, Gauzit R, et al: Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive casre units. Crit Care 2011; 15:R17
13. Heenen S, Jacobs F, Vincent J-L: Antibiotic strategies in severe nosocomial sepsis: Why do we not de-escalate more often? Crit Care Med 2012; 40:1404-1409
14. Gomes Silva BN, Andriolo RB, Atallah AN, et al: De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev 2010; CD007934